dc.contributor.author | Hernández Hernández, José Luis | es_ES |
dc.contributor.author | Lisa, Marta | es_ES |
dc.contributor.author | Napal, Jose Javier | es_ES |
dc.contributor.author | Córdoba, Ana | es_ES |
dc.contributor.author | Olmos Martínez, José Manuel | es_ES |
dc.contributor.author | Ruiz, Sheila | es_ES |
dc.contributor.author | Sierra, Isabel | es_ES |
dc.contributor.author | García Sardina, Romina | es_ES |
dc.contributor.other | Universidad de Cantabria | es_ES |
dc.date.accessioned | 2022-05-16T14:55:38Z | |
dc.date.available | 2022-05-16T14:55:38Z | |
dc.date.issued | 2017 | es_ES |
dc.identifier.issn | 2578-7160 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10902/24839 | |
dc.description.abstract | Purpose
Our aim was a) to compare serum Hcy levels in patients with RVO and population-based controls, and b) to evaluate whether hyperhomocysteinemia is a risk factor for RVO.
Patients and methods
Prospective case-control study of all patients diagnosed with RVO at a tertiary-care hospital, and age-and sex-matched controls taking part in a population-based prospective cohort in the same geographic area. Differences in serum Hcy between both groups were analyzed by a general linear model adjusted for age, body mass index (BMI), glomerular filtration rate (GFR), hypertension, dyslipidemia, diabetes, tobacco use and alcohol intake. Besides, we tested the relationship between hyperhomocysteinemia (> 15 µmol/L) and RVO, by a stepwise logistic regression analysis.
Results
RVO patients (n = 85) had a higher prevalence of hypertension (p = 0.002), diabetes (p = 0.008), and dyslipidemia (p = 0.04) than controls (n = 82). Adjusted median Hcy levels were higher in RVO patients (p < 0.0001). Adjusted OR for hyperhomocysteinemia were 4.4 (95% CI, 2.0-9.3; p < 0.0001) in the overall sample, and 2.6 (95% CI, 1.04-6.6; p = 0.04) and 6.1 (95% CI, 1.7-21.6; p = 0.005) for men and women, respectively.
Conclusion
Patients with RVO have higher serum Hcy levels than age- and sex-matched population-based controls. Hyperhomocysteinemia seems to be a risk factor for RVO, independent of age, BMI, GFR and classical vascular risk factors. | es_ES |
dc.format.extent | 6 p. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Scholarly Pages | es_ES |
dc.rights | Attribution 4.0 International | * |
dc.rights | ©Los autores | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | J Ophthalmic Res Ocular Care 2017, 1(1):12-17 | es_ES |
dc.subject.other | Retinal vein occlusion | es_ES |
dc.subject.other | Homocysteine | es_ES |
dc.subject.other | Hyperhomocysteinemia | es_ES |
dc.subject.other | Risk factor | es_ES |
dc.title | Serum Homocysteine Levels in Patients with Retinal Vein Occlusion in a Spanish Population | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherVersion | https://www.doi.org/10.36959/936/560 | es_ES |
dc.rights.accessRights | openAccess | es_ES |
dc.identifier.DOI | 10.36959/936/560 | es_ES |
dc.type.version | publishedVersion | es_ES |